Disease Info Card

Paracoccidioidomycosis

Information about Paracoccidioidomycosis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Paracoccidioidomycosis

Most recent studies have shown that Paracoccidioidomycosis shares some biological mechanisms with acquired-immunodeficiency-syndrome, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, delayed-hypersensitivity, granuloma, histoplasmosis, infection-by-cryptococcus-neoformans, infective-disorder, inflammation, lobomycosis, lung-diseases, lung-diseases-fungal, mouth-diseases, mycoses, pulmonary-paracoccidioidomycosis, sporotrichosis, systemic-mycosis, tuberculosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Paracoccidioidomycosis, and have been seen in publications frequently: Cell Activation, Cell Proliferation, Cytokine Production, Excretion, Granuloma Formation, Host-pathogen Interaction, Humoral Immune Response, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Lymphocyte Proliferation, Macrophage Activation, Pathogenesis, Phagocytosis, Secretion, Sensitization, T Cell Proliferation, Transport, Virulence

Quite a number of genes have been found to play important roles in Paracoccidioidomycosis, such as ALB, CD4, CD8A, CTLA4, ENPP3, HTN3, IFNG, IL10, IL2, IL4, IL5, IL6, POMC, SCG2, SIGLEC1, SPINT2, TLR2, TLR4, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.